John V
Articles
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Jan 13, 2025 |
eprints.gla.ac.uk | Carolyn S P |John V
Butt, J. H. et al. (2025) Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial. Lancet Diabetes and Endocrinology, (doi: 10.1016/S2213-8587(24)00309-7) (In Press)Text345134.pdf - Published Version Available under License Creative Commons Attribution. 1MBAbstractBackground: Data on the effect of mineralocorticoid receptor antagonist therapy on HbA1c levels and new-onset diabetes are conflicting.
-
Nov 25, 2024 |
eprints.gla.ac.uk | Matthew M. Y |John V |Johannes F E
Badve, S. V. et al. (2024) Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes and Endocrinology, (doi: 10.1016/S2213-8587(24)00271-7) (PMID:39608381) (In Press)Text342922.pdf - Accepted Version Restricted to Repository staff only until 25 May 2025. Available under License Creative Commons Attribution Non-commercial No Derivatives.
-
Oct 3, 2024 |
dx.doi.org | Weijian Ding |Kexin Ma |Amy E. Childress |John V
Environmental Science & TechnologyCite this: Environ. Sci. Technol. 2024, XXXX, XXXClick to copy citationCitation copied!. This publication is licensed under CC-BY-NC-ND 4.0 . You are free to share (copy and redistribute) this article in any medium or format within the parameters below:Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted.
-
Jul 2, 2024 |
academic.oup.com | John V |Okunola Adenrele |Olufunbi Esther |Funmilayo Esther
Sachet water is the most common form of portable water commercially available in Nigeria. Using the murine sperm count and sperm abnormality assay, the germ cell toxicity of five common commercially available sachet waters in Nigeria was assessed in this study.
-
Feb 23, 2024 |
eprints.gla.ac.uk | John V
Bhatt, A. S. et al. (2024) Cost effectiveness of dapagliflozin for heart failure across the spectrum of ejection fraction: an economic evaluation based on pooled, individual participant data from the DELIVER and DAPA-HF trials. Journal of the American Heart Association, (doi: 10.1161/JAHA.123.032279) (PMID:38390793) (Early Online Publication)Text311225.pdf - Published Version Available under License Creative Commons Attribution.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →